When we look at developing countries, the state of oncology is dramatic. 40% of cancers in Africa would be preventable if HPV and hepatitis vaccines were widely used. In sub-Saharan Africa, only 10% of children with retinoblastoma are treated, compared to 90% of children with this eye cancer in France; diagnosis and treatment, however, cost less than 1,000 euros.
In terms of diagnosis, advances in modern oncology, anatomopathology, genetics and molecular biology now make it possible to very accurately characterize the type of cancer affecting a patient and provide them with individualized treatment. However, while this precision medicine and these protocols are increasingly common in our Western societies, they are almost non-existent in most low- and middle-income countries. Therefore, half of the world’s population is excluded from this progress…
Source: Le Figaro
